SUN Pharmaceutical Industries Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Moxifloxacin Export Records India — #11 Exporter, 15 Shipments, $401.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

SUN Pharmaceutical Industries Limited — Moxifloxacin Exporter #11 | $401.3K Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #11 for Moxifloxacin · $401.3K export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #11 Indian exporter of Moxifloxacin with $401.3K in export value and 15 verified shipments. SUN Pharmaceutical Industries Limited holds a 1.2% market share in Moxifloxacin exports across 6 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Moxifloxacin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Moxifloxacin?

Country	Value	Shipments	Share
MEXICO	$150.0K	3	55.2%
RUSSIA	$33.1K	3	12.2%
SOUTH AFRICA	$32.1K	2	11.8%
PHILIPPINES	$28.2K	2	10.4%
MYANMAR	$22.1K	4

Who Are the Top Buyers of Moxifloxacin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
GRADINTER S C	MEXICO	$50.0K	1
GRADINTER S.C	MEXICO	$50.0K	1
M S	MEXICO	$50.0K	1
AO RANBAXY	RUSSIA	$33.1K	3
RANBAXY PHARMACEUTICALS PTY LTD	SOUTH AFRICA	$32.1K	1
SUN PHARMA PHILIPPINES INC.	PHILIPPINES	$14.7K	1
M/S..	PHILIPPINES	$13.5K	1
MYIT MAHAR TRADING CO LIMITED	MYANMAR	$12.3K	1
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$9.7K	3
SUN PHARMACEUTICAL INDUSTRIES SAC	PERU	$6.2K	1

SUN Pharmaceutical Industries Limited supplies Moxifloxacin to 12 buyers globally. The largest buyer is GRADINTER S C (MEXICO), followed by GRADINTER S.C (MEXICO) and M S (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Moxifloxacin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
MIFLOKO EYE DROPS 0.5%W/V 1S MOXIFLOXACIN HYDROCHLORIDE OPTHALMIC SOLUTIONS USP ACT QTY.14994 X 1X 1	$50.0K	1
MIFLOKO-DELTA 0.5%W/V&0.1%W/V 5ML (MOXIFLOXACIN HCL AND DEXAMETHASONE SODIUM PHOPHATE EYE DROPS 0.5%W/V, 0.1% W/V, 5ML)	$50.0K	1
SAPCode 1152013 HSN Code 30042033 MIFLOKO DELTA 0 5 W V 0 1 W V 5ML 1 S MX PACK 01 01 Moxifloxacin HCL and Dexamethas	$50.0K	1
AVEBACT TAB 400mg (MOXIFLOXACIN HYDROCHL	$32.1K	1
MILFLOX EYE DROPS 0.5%W/V 5ML 1S (MOXIFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP,5ML) (QTY.7680 PACK X 01*01)	$14.7K	1
MILFLOX EYE DROPS 0.5%W/V 5ML 1S PH (MOXIFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP,5ML) (QTY.7116PACK X 01*01)	$13.5K	1
MILFLOX EYE DROPS 0.5%W/V 5ML 1S MM QTY. 4300 BOXOF01BTLMOXIFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP	$12.3K	1
XAFLOM EYE DROPS 0.5%W/V CONTAINS MOXIFLOXACIN HCL OPHTHALMIC SOLUTION (PACK SIZE: 7617 X01X01)NOS	$11.2K	1
XAFLOM EYE DROPS 0.5% W/V PACK:01*01 BATCH:BAF0236A CONTS. MOXIFLOXACIN HCL OPHTHALMIC SOLUTION	$11.0K	1
XAFLOM EYE DROPS 0.5% W/V PACK:01*01 BATCH: BAF0191A CONTAINS MOXIFLOXACIN HCL OPHTHALMIC SOLUTION	$10.9K	1

SUN Pharmaceutical Industries Limited exports 16 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MIFLOKO EYE DROPS 0.5%W/V 1S MOXIFLOXACIN HYDROCHLORIDE OPTH with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	MACLEODS PHARMACEUTICALS LIMITED	$656.3K	20	10	$32.8K
10	MANKIND PHARMA LIMITED	$452.0K	11	2	$41.1K
11	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$401.3K	15	6	$26.8K
13	HETERO LABS LIMITED	$260.9K	7	3	$37.3K
14	INDOCO REMEDIES LIMITED	$239.8K	18	8	$13.3K

SUN Pharmaceutical Industries Limited ranks #11 among 336 Indian Moxifloxacin exporters. Average shipment value of $26.8K compared to the market average of $42.4K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and MANKIND PHARMA LIMITED.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Moxifloxacin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 16 individual customs records matching SUN Pharmaceutical Industries Limited exporting Moxifloxacin, covering 16 formulations to 7 countries via 12 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

SUN Pharmaceutical Industries Limited — Moxifloxacin Exporter Profile

SUN Pharmaceutical Industries Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from SUN Pharmaceutical Industries Limited?

What Is India's Total Moxifloxacin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Moxifloxacin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Moxifloxacin Exporters?

What Moxifloxacin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

Mexico — COFEPRIS

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Moxifloxacin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from SUN Pharmaceutical Industries Limited

Moxifloxacin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source